Newsroom
Latest news
Investors
06 May 2021
Lotus declares cash dividends
Lotus Pharmaceutical Co., Ltd. (“Lotus” or “the Company”, Taiwan TWSE ticker: 1795) today announced that its Board of Directors resolved to declare cash dividends of NT$0.35 per share out of FY2020 distributable profits. This is not only the first time Lotus is able to paying dividend since the joint-force with Alvogen in 2014, after offsetting all the accumulated deficits by...
Business
26 November 2021
Strong investor consortium to accelerate Lotus’s global expansion
Investors
18 November 2021
Lotus attends Fubon Securities online investment conference
Business
11 November 2021
Lotus signs exclusive licensing and commercialization agreement with PharmaMar for Zepzelca® (lurbinectedin) in Taiwan
Investors
11 November 2021
Lotus hosts third quarter 2021 results investor conference
Investors
10 November 2021
Monthly sales report for Oct 2021
Investors
12 October 2021
Monthly sales report for Sep 2021
Charity
14 September 2021
Lotus receives 2021 Asia Responsible Enterprise Awards
Investors
10 September 2021
Monthly sales report for Aug 2021
Investors
12 August 2021